Body composition and bone status in relation to microvascular damage in systemic sclerosis patients

Abstract

Aim

To evaluate, in Systemic sclerosis (SSc) patients, the body composition and the bone status according to the peripheral microcirculatory condition, assessed and scored by nailfold videocapillaroscopy (NVC, “Early”, “Active”, “Late” patterns).

Methods

Body composition and bone mineral density (BMD) were assessed by Dual X-ray absorptiometry and dedicated software (GE Lunar USA) in 37 female SSc patients classified according to the 2013 EULAR/ACR criteria and 40 sex-matched healthy subjects. Clinical, laboratory, body composition and bone parameters were analyzed according to the different NVC patterns. Means were compared by the Student’s t test or one-way analysis of variance; medians were compared by the Kruskal–Wallis test; and frequencies by the chi-square test.

Results

Higher prevalence of vertebral (21% vs 7%) and femoral (35% vs 7%) osteoporosis (OP) was found in SSc. Particularly SSc patients with “Late” NVC pattern showed a significantly higher prevalence of vertebral (p = 0.018) and femoral OP (p = 0.016). Regional assessment of bone mass (BM) in seven different body areas showed a significantly lower BMD only at the total spine (p = 0.008) and femoral neck (p = 0.027) in advanced microvascular damage. Patients with “Late” NVC pattern showed a lower whole-body lean mass (LM) compared to “Early” and “Active” NVC patterns, particularly at upper limbs. To note, in all body sites, BMD correlates with LM and BMC according to NVC pattern severity.

Conclusions

SSc patients with most severe microvascular damage show a significantly altered body composition and bone status suggesting a strong link between microvascular failure and associated muscle/bone sufferance.

This is a preview of subscription content, access via your institution.

References

  1. 1.

    Cutolo M, Soldano S, Smith V (2019) Pathophysiology of systemic sclerosis: current understanding and new insights. Expert Rev Clin Immunol 15(7):753–764. https://doi.org/10.1080/1744666X.2019.1614915

    CAS  Article  PubMed  Google Scholar 

  2. 2.

    Soldano S, Pizzorni C, Paolino S, Trombetta AC, Montagna P, Brizzolara R, Ruaro B, Sulli A, Cutolo M (2017) Alternatively activated (M2) macrophage phenotype is inducible by endothelin-1 in cultured human macrophages. PLoS ONE 12(3):e0175238. https://doi.org/10.1371/journal.pone.0175238

    Article  PubMed  PubMed Central  Google Scholar 

  3. 3.

    Barsotti S, Orlandi M, Codullo V, Di Battista M, Lepri G, Della Rossa A, Guiducci S (2019) One year in review 2019: systemic sclerosis. Clin Exp Rheumatol 37 Suppl 119(4):3–14

    Google Scholar 

  4. 4.

    Smith V, Distler O, Cutolo M (2019) Might nailfold capillaroscopy be a "proxy" for lung involvement in connective tissue diseases? J Rheumatol 46(9):1061–1063. https://doi.org/10.3899/jrheum.181408

    Article  PubMed  Google Scholar 

  5. 5.

    Cutolo M, Paolino S, Smith V (2019) Nailfold capillaroscopy in rheumatology: ready for the daily use but with care in terminology. Clin Rheumatol 38(9):2293–2297. https://doi.org/10.1007/s10067-019-04716

    Article  PubMed  Google Scholar 

  6. 6.

    Sulli A, Paolino S, Pizzorni C, Ferrari G, Pacini G, Pesce G, Carmisciano L, Smith V, Cutolo M (2019) Progression of nailfold capillaroscopic patterns and correlation with organ involvement in systemic sclerosis: a 12 year study. Rheumatology (Oxford). https://doi.org/10.1093/rheumatology/kez374 [Epub ahead of print]

    Article  Google Scholar 

  7. 7.

    Montella A, Corallo C, Pastorelli M, Capecchi M, Voglino M, Ruocco G, Wolf G, Giordano N (2019) Association between microvascular and macrovascular damage in patients with systemic sclerosis: an upper limb echo-color-doppler and nailfold videocapillaroscopy study. J Biol Regul Homeost Agents 33(6):1897–1902. https://doi.org/10.23812/19-192-L

    CAS  Article  PubMed  Google Scholar 

  8. 8.

    Caimmi C, Caramaschi P, Venturini A, Bertoldo E, Vantaggiato E, Viapiana O, Ferrari M, Lippi G, Frulloni L, Rossini M (2018) Malnutrition and sarcopenia in a large cohort of patients with systemic sclerosis. Clin Rheumatol 37(4):987–997. https://doi.org/10.1007/s10067-017-3932-y

    CAS  Article  PubMed  Google Scholar 

  9. 9.

    Corallo C, Fioravanti A, Tenti S, Pecetti G, Nuti R, Giordano N (2019) Sarcopenia in systemic sclerosis: the impact of nutritional clinical and laboratory features. Rheumatol Int 39(10):1767–1775. https://doi.org/10.1007/s00296-019-04401-w

    CAS  Article  PubMed  Google Scholar 

  10. 10.

    Marighela TF, Genaro Pde S, Pinheiro MM, Szejnfeld VL, Kayser C (2013) Risk factor for body composition abnormalities in systemic sclerosis. Clin Rheumatol 32(7):1037–1044. https://doi.org/10.1007/s10067-013-2235-1

    Article  PubMed  Google Scholar 

  11. 11.

    Siegert E, March C, Otten L, Makowka A, Preis E, Buttgereit F, Riemekasten G, Müller-Werdan U, Norman K (2018) Prevalence of sarcopenia in systemic sclerosis: assessing body composition and functional disability in patients with systemic sclerosis. Nutrition 55–56:51–55. https://doi.org/10.1016/j.nut.2018.03.046

    Article  PubMed  Google Scholar 

  12. 12.

    Caimmi C, Caramaschi P, Barausse G, Orsolini G, Idolazzi L, Gatti D, Viapiana O, Adami S, Biasi D, Rossini M (2016) Bone metabolism in a large cohort of patients with systemic sclerosis. Calcif Tissue Int 99(1):23–29. https://doi.org/10.1007/s00223-016-0119-5

    CAS  Article  PubMed  Google Scholar 

  13. 13.

    Crepaldi G, Romanato G, Tonin P, Maggi S (2007) Osteoporosis and body composition. J Endocrinol Invest 30(6 Suppl):42–47

    CAS  PubMed  Google Scholar 

  14. 14.

    Thietart S, Louati K, Gatfosse M, Sornay-Rendu E, Gaigneux E, Lemeunier L, Delmaire P, Riviere S, Mahevas T, Sellam J, Berenbaum F, Fain O, Roland C, Mekinian A (2018) Overview of osteo-articular involvement in systemic sclerosis: Specific risk factors, clinic-sonographic evaluation, and comparison with healthy women from the French OFELY cohort. Best Pract Res Clin Rheumatol 32(4):591–604. https://doi.org/10.1016/j.berh.2019.01.008

    Article  PubMed  Google Scholar 

  15. 15.

    Ruaro B, Casabella A, Paolino S, Pizzorni C, Alessandri E, Seriolo C, Botticella G, Molfetta L, Odetti P, Smith V, Cutolo M (2018) Correlation between bone quality and microvascular damage in systemic sclerosis patients. Rheumatology 57(9):1548–1554. https://doi.org/10.1093/rheumatology/key130

    CAS  Article  PubMed  Google Scholar 

  16. 16.

    Atteritano M, Sorbara S, Bagnato G, Miceli G, Sangari D, Morgante S, Visalli E, Bagnato G (2013) Bone mineral density, bone turnover markers and fractures in patients with systemic sclerosis: a case control study. PLoS One 20 8(6):e6699. https://doi.org/10.1371/journal.pone.0066991

    CAS  Article  Google Scholar 

  17. 17.

    Omair MA, Pagnoux C, McDonald-Blumer H, Johnson SR (2013) Low bone density in systemic sclerosis. A systematic review. J Rheumatol 40:1881–1890. https://doi.org/10.3899/jrheum.130032

    Article  PubMed  Google Scholar 

  18. 18.

    Maruotti N, Corrado A, Cantatore FP (2014) Osteoporosis and rheumatic diseases. Reumatismo 66:125–135. https://doi.org/10.4081/reumatismo.2014.785

    CAS  Article  PubMed  Google Scholar 

  19. 19.

    Alonso N, Ralston SH (2014) Unveiling the mysteries of the genetics of osteoporosis. J Endocrinol Invest 37(10):925–934. https://doi.org/10.1007/s40618-014-0149-7

    CAS  Article  PubMed  Google Scholar 

  20. 20.

    Payne GW, Bearden SE (2006) The microcirculation of skeletal muscle in aging. Microcirculation 13(4):275–277

    CAS  Article  Google Scholar 

  21. 21.

    Hendrickse P, Degens H (2019) The role of the microcirculation in muscle function and plasticity. Muscle Res Cell Motil 40(2):127–140. https://doi.org/10.1007/s10974-019-09520-2

    CAS  Article  Google Scholar 

  22. 22.

    Carulli C, Innocenti M, Brandi ML (2013) Bone vascularization in normal and disease conditions. Front Endocrinol (Lausanne) 26 4:106. https://doi.org/10.3389/fendo.2013.00106

    Article  Google Scholar 

  23. 23.

    Binder EF (2008 Jun) Kiel DP (2008) Genetics of the musculoskeletal system: a pleiotropic approach. J Bone Miner Res 23(6):788–802. https://doi.org/10.1359/jbmr.080218

    Article  Google Scholar 

  24. 24.

    Van Den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP, Medsger TA Jr, Carreira PE, Riemekasten G, Clements PJ, Denton CP, Distler O, Allanore Y, Furst DE, Gabrielli A, Mayes MD, van Laar JM, Seibold JR, Czirjak L, Steen VD, Inanc M, Kowal-Bielecka O, Müller-Ladner U, Valentini G, Veale DJ, Vonk MC, Walker UA, Chung L, Collier DH, Csuka ME, Fessler BJ, Guiducci S, Herrick A, Hsu VM, Jimenez S, Kahaleh B, Merkel PA, Sierakowski S, Silver RM, Simms RW, Varga J, Pope JE (2013) 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum 65(11):2737–2747. https://doi.org/10.1002/art.38098

    Article  PubMed  PubMed Central  Google Scholar 

  25. 25.

    Smith V, Scirè CA, Talarico R, Airo P, Alexander T, Allanore Y, Bruni C, Codullo V, Dalm V, De Vries-Bouwstra J, Della Rossa A, Distler O, Galetti I, Launay D, Lepri G, Mathian A, Mouthon L, Ruaro B, Sulli A, Tincani A, Vandecasteele E, Vanhaecke A, Vanthuyne M, Van den Hoogen F, Van Vollenhoven R, Voskuyl AE, Zanatta E, Bombardieri S, Burmester G, Eurico FJ, Frank C, Hachulla E, Houssiau F, Mueller-Ladner U, Schneider M, van Laar JM, Vieira A, Cutolo M, Mosca M, Matucci-Cerinic M (2018) Systemic sclerosis: state of the art on clinical practice guidelines. RMD Open 18 4(Suppl 1):e000782. https://doi.org/10.1136/rmdopen-2018-000782

    Article  Google Scholar 

  26. 26.

    Peterson CM, Thomas DM, Blackburn GL, Heymsfield SB (2016) Universal equation for estimating ideal body weight and body weight at any BMI. Am J Clin Nutr 103(5):1197–1203. https://doi.org/10.3945/ajcn.115.121178

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  27. 27.

    Ec L, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, Rowell N, Wollheim F (1998) Scleroderma (systemic sclerosis) classification, subsets and pathogenesis. J Rheumatol 15(2):202–205

    Google Scholar 

  28. 28.

    Frauenfelder T, Winklehner A, Nguyen TD, Dobrota R, Baumueller S, Maurer B, Distler O (2014) Screening for interstitial lung disease in systemic sclerosis: performance of high-resolution CT with limited number of slices: a prospective study. Ann Rheum Dis 73(12):2069–2073. https://doi.org/10.1136/annrheumdis-2014-205637

    Article  PubMed  Google Scholar 

  29. 29.

    Galliè N, Humbert M, Vachiery JI, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Gomez Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M, ESC Scientific Document Group (2016) 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulomonary hypertension. Eur Heart J 37(1):67–119. https://doi.org/10.1016/j.rec.2016.01.002

    Article  Google Scholar 

  30. 30.

    Vandecasteele E, Drieghe B, Melsens K, Thevissen K, De Pauw M, Deschepper E, Decuman S, Bonroy C, Piette Y, De Keyser F, Brusselle G, Smith V (2017) Screening for pulmonary arterial hypertension in an unselected prospective systemic sclerosis cohort. Eur Respir J 49(5):1602275. https://doi.org/10.1183/13993003.02275-2016

    Article  PubMed  Google Scholar 

  31. 31.

    Parasuraman S, Walker S, Loudon BL, Gollop ND, Wilson AM, Lowery C, Frenneaux MP3, (2016) Assessment of pulmonary artery pressure by echocardiography: a comprehensive review. Int J Cardiol Hear Vasc 12:45–51. https://doi.org/10.1016/j.ijcha.2016.05.011

    Article  Google Scholar 

  32. 32.

    Giordano N, Montella A, Corallo C, Ruocco G, Chirico C, Palazzuoli A, Nuti R, Pecetti G (2015) Pulmonary hypertension: a correct diagnosis for a suitable therapy in scleroderma patients. Clin Exp Rheumatol 33(4 Suppl 91):S182–S189

    PubMed  Google Scholar 

  33. 33.

    Lóránd V, Czirják L, Minier T (2014) Musculoskeletal involvement in systemic sclerosis. Presse Med 43:e315–e328. https://doi.org/10.1016/j.lpm.2014.03.027

    Article  PubMed  Google Scholar 

  34. 34.

    Ta M, Bombardieri S, Czirjak L, Scorza R, Della Rossa A, Bencivelli W (2003) Assessment of disease severity and prognosis. Clin Exp Rheumatol 21(Suppl. 29):S42–S46

    Google Scholar 

  35. 35.

    Smith V, Vanhaecke A, Herrick ALerrick, Distler O, Guerra MG, Denton CP, Deschepper E, Foeldvari I, Gutierrez M, Hachulla E, Ingegnoli F, Kubo S, Müller-Ladner U, Riccieri V, Sulli A, van Laar JM, Vonk MC, Walker UA, Cutolo M, EULAR Study Group on Microcirculation in Rheumatic Diseases (2019) EULAR Study Group on Microcirculation in Rheumatic Diseases. Fast track algorithm: how to differentiate a "scleroderma pattern" from a "non-scleroderma pattern". Autoimmun Rev 18(11):102394. https://doi.org/10.1016/j.autrev.2019.102394

    Article  PubMed  Google Scholar 

  36. 36.

    Avouac J, Lepri G, Smith V, Toniolo E, Hurabielle C, Vallet A, Amrouche F, Kahan A, Cutolo M, Allanore Y (2017) Sequential nailfold videocapillaroscopy examinations have responsiveness to detect organ progression in systemic sclerosis. Semin Arthritis Rheum 47(1):86–94. https://doi.org/10.1016/j.semarthrit.2017.02.006

    Article  PubMed  Google Scholar 

  37. 37.

    Sulli A, Secchi ME, Pizzorni C, Cutolo M (2008) Scoring the nailfold microvascular changes during the capillaroscopic analysis in systemic sclerosis patients. Ann Rheum Dis 67:885–887

    CAS  Article  Google Scholar 

  38. 38.

    Wildt M, Hesselstrand R, Scheja A, Akesson A (1999) Capillary density in patients with systemic sclerosis, as determined by microscopy counts and compared with computer based analysis. Clin Exp Rheumatol 17:219–222

    CAS  PubMed  Google Scholar 

  39. 39.

    Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR, Garry PJ, Lindeman RD (1998) Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 147(8):755–763

    CAS  Article  Google Scholar 

  40. 40.

    Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinková E, Vandewoude M, Zamboni M, European Working Group on Sarcopenia in Older People (2010) Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 239(4):412–423. https://doi.org/10.1093/ageing/afq034

    Article  Google Scholar 

  41. 41.

    Lewiecki EM (2005) Review of guidelines for bone mineral density testing and treatment of osteoporosis. Curr Osteoporos Rep 3(3):75–83

    Article  Google Scholar 

  42. 42.

    Hygum K, Starup-Linde J, Langdahl BL (2019) Diabetes and bone. Osteoporos Sarcopenia 5(2):29–37. https://doi.org/10.1016/j.afos.2019.05.001

    Article  PubMed  Google Scholar 

  43. 43.

    Corrado A, Colia R, Mele A, Di Bello V, Trotta A, Neve A, Cantatore FP (2015) Relationship between body mass composition, bone mineral density, skin fibrosis and 25(oh) vitamin d serum levels in systemic sclerosis. PLoS One 16 10(9):e0137912. https://doi.org/10.1371/journal.pone.0137912

    CAS  Article  Google Scholar 

  44. 44.

    Souza RB, Borges CT, Takayama L, Aldrighi JM, Pereira RM (2006) Systemic sclerosis and bone loss: the role of the disease and body composition. Scand J Rheumatol 35(5):384–387

    CAS  Article  Google Scholar 

  45. 45.

    Corallo C, Cutolo M, Volpi N, Franci D, Aglianò M, Montella A, Chirico C, Gonnelli S, Nuti R, Giordano N (2017) Histopathological findings in systemic sclerosis-related myopathy: fibrosis and microangiopathy with lack of cellular inflammation. Ther Adv Musculoskelet Dis 9(1):3–10. https://doi.org/10.1177/1759720X16671928

    CAS  Article  PubMed  Google Scholar 

  46. 46.

    Brandi ML, Collin-Osdoby P (2006) Vascular biology and the skeleton. J Bone Miner Res 21:183–192

    CAS  Article  Google Scholar 

  47. 47.

    Bijlsma AY, Meskers MC, Molendijk M, Westendorp RG, Sipilä S, Stenroth L, Sillanpää E, McPhee JS, Jones DA, Narici M, Gapeyeva H, Pääsuke M, Seppet E, Voit T, Barnouin Y, Hogrel JY, Butler-Browne G, Maier AB (2013) Diagnostic measures for sarcopenia and bone mineral density. Osteoporosis Int 24:2681–2691. https://doi.org/10.1007/s00198-013-2376-8

    CAS  Article  Google Scholar 

  48. 48.

    Kang D, Liu Z, Wang Y, Zhang H, Feng X, Cao W, Wang P (2014) Relationship of body composition with bone mineral density in northern Chinese men by body mass index levels. J Endocrinol Invest 37(4):359–367. https://doi.org/10.1007/s40618-013-0037-6

    CAS  Article  PubMed  Google Scholar 

  49. 49.

    Marot M, Valéry A, Esteve E, Bens G, Müller A, Rist S, Toumi H, Lespessailles E (2015) Prevalence and predictive factors of osteoporosis in systemic sclerosis patients: a case-control study. Oncotarget 6(17):14865–14873

    Article  Google Scholar 

  50. 50.

    Sulli A, Ruaro B, Smith V, Pizzorni C, Zampogna G, Gallo M, Cutolo M (2013) Progression of nailfold microvascular damage and antinuclear antibody pattern in systemic sclerosis. J Rheumatol 40(5):634–639. https://doi.org/10.3899/jrheum.121089

    CAS  Article  PubMed  Google Scholar 

  51. 51.

    Corallo C, Cheleschi S, Cutolo M, Soldano S, Fioravanti A, Volpi N, Franci D, Nuti R, Giordano N (2019) Antibodies against specific extractable nuclear antigens (ENAs) as diagnostic and prognostic tools and inducers of a profibrotic phenotype in cultured human skin fibroblasts: are they functional? Arthritis Res Ther 24 21(1):152. https://doi.org/10.1186/s13075-019-1931-x

    CAS  Article  Google Scholar 

  52. 52.

    Alonso AC, Gonçalves TA, Almeida JKA, Machado-Lima A, Ernandes RC, Greve JMD, Garcez-Leme LE (2018) Relationship between bone mineral density and body composition in ederly. Acta Ortop Brasil 26(1):27–29. https://doi.org/10.1590/1413-785220182601182340

    Article  Google Scholar 

  53. 53.

    Ho-Pham LT, Nguyen ND, Lai TQ, Nguyen TV (2010) Contributions of lean mass and fat mass to bone mineral density: a study in postmenopausal women. BMC Musculoskelet Disord 26(11):59. https://doi.org/10.1186/1471-2474-11-59

    Article  Google Scholar 

  54. 54.

    Pluijm SM, Visser M, Smit JH, Popp-Snijders C, Roos JC, Lips P (2001) Determinants of bone mineral density in older men and women: body composition as mediator. J Bone Miner Res 16(11):2142–2151

    CAS  Article  Google Scholar 

  55. 55.

    Karasik D, Kiel DP (2008) Genetics of the muscoloskeletal system: a pleiotropic approach. J Bone Miner Res Off J Am Soc Bone Miner Res 23(6):788–802. https://doi.org/10.1359/jbmr.080218

    CAS  Article  Google Scholar 

  56. 56.

    Bilha SC, Branisteanu D, Buzduga C, Constantinescu D, Cianga P, Anisie E, Covic A, Ungureanu MC (2018) Body composition and circulating estradiol are the main bone density predictors in healthy young and middle-aged men. J Endocrinol Invest 41(8):995–1003. https://doi.org/10.1007/s40618-018-0826-z

    CAS  Article  PubMed  Google Scholar 

  57. 57.

    Elhai M, Meune C, Boubaya M, Avouac J, Hachulla E, Balbir-Gurman A, Riemekasten G, Airò P, Joven B, Vettori S, Cozzi F, Ullman S, Czirják L, Tikly M, Müller-Ladner U, Caramaschi P, Distler O, Iannone F, Ananieva LP, Hesselstrand R, Becvar R, Gabrielli A, Damjanov N, Salvador MJ, Riccieri V, Mihai C, Szücs G, Walker UA, Hunzelmann N, Martinovic D, Smith V, Müller CS, Montecucco CM, Opris D, Ingegnoli F, Vlachoyiannopoulos PG, Stamenkovic B, Rosato E, Heitmann S, Distler JHW, Zenone T, Seidel M, Vacca A, Langhe E, Novak S, Cutolo M, Mouthon L, Henes J, Chizzolini C, Mühlen CAV, Solanki K, Rednic S, Stamp L, Anic B, Santamaria VO, De Santis M, Yavuz S, Sifuentes-Giraldo WA, Chatelus E, Stork J, Laar JV, Loyo E, de la Peña G, Lefebvre P, Eyerich K, Cosentino V, Alegre-Sancho JJ, Kowal-Bielecka O, Rey G, Matucci-Cerinic M, Allanore Y, EUSTAR group, (2017) Mapping and predicting mortality from systemic sclerosis. Ann Rheum Dis 76(11):1897–1905. https://doi.org/10.1136/annrheumdis-2017-211448

    Article  PubMed  Google Scholar 

  58. 58.

    Kanis JA, Melton LJ, Christiansen C, Johnston CC, Khaltaev N (1994) The diagnosis of osteoporosis. J Bone Miner Res 9(8):1137–1141

    CAS  Article  Google Scholar 

  59. 59.

    Smith V, Herrick AL, Ingegnoli F, Damjanov N, Angelis DCP, Distler O, Espejo K, Foeldvari I, Frech T, Garro B, Gutierrez M, Gyger G, Hachulla E, Hesselstrand R, Iagnocco A, Kayser C, Melsens K, Müller-Ladner U, Pizzorni C, Radic M, Riccieri V, Snow M, Stevens W, Sulli A, van Laar JM, Vonk MC, Vanhaecke A, Cutolo M, EULAR Study Group on Microcirculation in Rheumatic Diseases, and the Scleroderma Clinical Trials Consortium Group on Capillaroscopy (2020) Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis. EULAR Study Group on Microcirculation in Rheumatic Diseases and the Scleroderma Clinical Trials Consortium Group on Capillaroscopy. Autoimmun Rev. https://doi.org/10.1016/j.autrev.2020.102458 [Epub ahead of print]

    Article  PubMed  Google Scholar 

  60. 60.

    Jaeger VK, Wirz EG, Allanore Y, Rossbach P, Riemekasten G, Hachulla E, Distler O, Airò P, Carreira PE, Balbir Gurman A, Tikly M, Vettori S, Damjanov N, Müller-Ladner U, Distler JH, Li M, Walker UA, EUSTAR co-authors (2016) Incidences and risk factors of organ manifestations in the early course of systemic sclerosis: a longitudinal EUSTAR study. PLoSOne 11(10):e0163894. https://doi.org/10.1371/journal.pone.0163894

    CAS  Article  Google Scholar 

  61. 61.

    Cutolo M, Herrick AL, Distler O, Becker MO, Beltran E, Carpentier P, Ferri C, Inanç M, Vlachoyiannopoulos P, Chadha-Boreham H, Cottreel E, Pfister T, Rosenberg D, Torres JV, Smith V, CAP Study Investigators (2016) Nailfold videocapillaroscopic features and other clinical risk factors for digital ulcers in systemic sclerosis: a multicenter prospective cohort study. Arthritis Rheumatol 68(10):2527–2539. https://doi.org/10.1002/art.39718

    Article  PubMed  PubMed Central  Google Scholar 

  62. 62.

    Pizzorni C, Sulli A, Paolino S, Ruaro B, Smith V, Trombetta AC, Cutolo M (2017) Progression of organ involvement in systemic sclerosis patients with persistent "Late" nailfold capillaroscopic pattern of microangiopathy: a prospective study. J Rheumatol 44(12):1941–1942. https://doi.org/10.3899/jrheum.170485

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

Dr. De Gregorio Sara for graphic support. V. Smith is Senior Clinical Investigator of the Research Foundation - Flanders (Belgium) (FWO) (grant no.: 1.8.029.15N).

Author information

Affiliations

Authors

Contributions

I testify on behalf of all co-authors that in our article. SP, EG, FG, AC, GF, MP, MA, FG, CP, AS, VS, MC submitted to Journal of Endocrinological Investigation: (1) the material has not been published in whole or in part elsewhere; (2) the manuscript is not currently being considered for publication in another journal; (3) all authors have been personally and actively involved in substantive work leading to the manuscript, and will hold themselves jointly and individually responsible for its content.

Corresponding author

Correspondence to S. Paolino.

Ethics declarations

Conflict of interest

No conflict of interest to declare.

Research involving human participants and/or animals

The study was conducted in accordance with the principles of Good Clinical Practices and the declaration of Helsinski. All the standard clinical investigations performed at the Scleroderma Clinic have been approved by local Ethical Board Committee (EBC).

Informed consent

All patients provided at the right time, the mandatory signed informed consent form to enter the Scleroderma Clinic assistance.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Paolino, S., Gotelli, E., Goegan, F. et al. Body composition and bone status in relation to microvascular damage in systemic sclerosis patients. J Endocrinol Invest 44, 255–264 (2021). https://doi.org/10.1007/s40618-020-01234-4

Download citation

Keywords

  • Systemic sclerosis
  • Body composition
  • Bone mineral density
  • Sarcopenia
  • Capillaroscopy
  • Connective tissue diseases
  • Rheumatic diseases